These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6987542)

  • 41. [Rooms free of pathogenic bacteria. Transfusion of autologous bone marrow and intensive chemotherapy].
    Schneider M
    Sem Ther; 1968 Apr; 44(4):259-61. PubMed ID: 4927218
    [No Abstract]   [Full Text] [Related]  

  • 42. [The risks of the antineoplastic chemotherapy and the treatment of complications caused by cytostatic agents (author's transl)].
    Gürtler R
    Arch Geschwulstforsch; 1980; 50(2):141-52. PubMed ID: 7436698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Side-effects of antitumor chemotherapy].
    Ghione M
    Minerva Med; 1980 Apr; 71(15):1095-9. PubMed ID: 7375021
    [No Abstract]   [Full Text] [Related]  

  • 44. [Protective effect of highly polymerized desoxyribonucleic acid against medullary aplasia following intense anti-cancer chemotherapy or irradiation with radiocobalt].
    Wicart L; Vendrely C
    C R Acad Hebd Seances Acad Sci D; 1967 Feb; 264(6):857-60. PubMed ID: 4963539
    [No Abstract]   [Full Text] [Related]  

  • 45. [Optimally spaced after-treatment with multiplicative effect. A cancer therapy principle of universal character].
    von Ardenne M
    Arch Geschwulstforsch; 1973; 42(4):324-44. PubMed ID: 4371114
    [No Abstract]   [Full Text] [Related]  

  • 46. [The use of peripheral blood progenitor cells as an autologous hematopoietic support in high-dose chemotherapy. II. The experience of the Hematological Intensive Care Unit of the IPOFG. Franciso Gentil Portuguese Institute of Oncology].
    Silva MR; Passos-Coelho JL; da Costa FL; Machado MA; Miranda N; Miranda MH; Parreira A
    Acta Med Port; 1999; 12(7-11):275-81. PubMed ID: 10707465
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Adverse effects of antineoplastic agents and their prevention].
    Furue H
    Nihon Rinsho; 1975 May; 33(5):1897-903. PubMed ID: 1171285
    [No Abstract]   [Full Text] [Related]  

  • 48. Did we focus on the most important issues in the use of growth factors and stem-cell transplantation?
    Gulati SC
    J Clin Oncol; 1994 Apr; 12(4):650-2. PubMed ID: 7908688
    [No Abstract]   [Full Text] [Related]  

  • 49. The use of autologous transplantation in the treatment of malignant disorders.
    Territo M
    J Rheumatol Suppl; 1997 May; 48():36-40. PubMed ID: 9150116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation.
    Elkordy M; Crump M; Vredenburgh JJ; Petros WP; Hussein A; Rubin P; Ross M; Gilbert C; Modlin C; Meisenberg B; Coniglio D; Rabinowitz J; Laughlin M; Kurtzberg J; Peters WP
    Bone Marrow Transplant; 1997 Feb; 19(4):315-22. PubMed ID: 9051240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Use of deep hypothermia (-196 degrees) for conserving bone marrow in radiation and chemotherapy of oncologic patients].
    Pushkar' NS; Datsenko BM; Itkin IuA; Kruglianskaia EA; Shchelokova AV
    Vrach Delo; 1969 Feb; 2():71-5. PubMed ID: 4888601
    [No Abstract]   [Full Text] [Related]  

  • 52. [Platinum-based chemotherapy in renal transplant recipients with malignancies: a case report and review of literature].
    Wójcik J; Bułło B; Jassem J; Rutkowski B
    Pol Merkur Lekarski; 1998 Sep; 5(27):145-6. PubMed ID: 10101481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pulmonary toxicity secondary to cancer treatment.
    Wickham R
    Oncol Nurs Forum; 1986; 13(5):69-76. PubMed ID: 3529048
    [No Abstract]   [Full Text] [Related]  

  • 54. High-dose therapy in breast cancer: out of favor but not out of promise.
    Glück S; Stewart D
    Bone Marrow Transplant; 2000 May; 25(10):1017-9. PubMed ID: 10828859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma.
    Matthay KK
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S21-4. PubMed ID: 8971402
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-dose chemotherapy for malignancies: a review.
    Roman-Unfer S; Bitran JD
    Compr Ther; 1996 Feb; 22(2):107-20. PubMed ID: 8689864
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation and management of the dental patient with cancer I: Complications associated with chemotherapy or bone marrow transplantation.
    Cutler LS
    J Conn State Dent Assoc; 1987 Oct; 61(4):236-8. PubMed ID: 2966187
    [No Abstract]   [Full Text] [Related]  

  • 58. Malignancy-associated pulmonary veno-occlusive disease: report of a case following autologous bone marrow transplantation and review.
    Salzman D; Adkins DR; Craig F; Freytes C; LeMaistre CF
    Bone Marrow Transplant; 1996 Oct; 18(4):755-60. PubMed ID: 8899191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term pulmonary sequelae after autologous bone marrow transplantation in children without total body irradiation.
    Nenadov Beck M; Meresse V; Hartmann O; Gaultier C
    Bone Marrow Transplant; 1995 Dec; 16(6):771-5. PubMed ID: 8750268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Guillain-Barré syndrome after autologous bone marrow transplantation for breast cancer: report of two cases.
    Myers SE; Williams SF
    Bone Marrow Transplant; 1994 Mar; 13(3):341-4. PubMed ID: 8199578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.